Lv1
60 积分 2025-12-28 加入
A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD/MASH: from mechanism to therapy
10小时前
求助中
The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019
10小时前
已关闭
Current status and future trends of the global burden of MASLD
11小时前
已完结
Metabolic dysfunction-associated steatotic liver disease: A pathophysiology and clinical framework to face the present and the future
12小时前
已完结
Exploring Phosphatase and Tensin Homologue Deleted on Chromosome Ten (PTEN) as a Potential Therapeutic Target for Cardiac Hypertrophy
14天前
已完结
皖公网安备34019202002308
